What's breaking now, across thousands of outlets.
The "most favored nation" drug pricing deals that Pfizer and Eli Lilly signed with the Trump administration suggest the companies will give the government a share of increased revenue they generate from raising prices abroad. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Trump administration is rolling out a new model that aims to bring most-favored nation pricing to the Medicaid space.
(MedPage Today) -- On September 9, the 5th Circuit Court of Appeals heard oral arguments in Louisiana et al. v. FDA et al., a case challenging the FDA's regulation of mifepristone (Mifeprex).
A new study of nearly 4,000 older adults reveals that daily variations in the stress hormone cortisol predict cognitive decline.
CVS Health's Omnicare unit has started voluntary Chapter 11 bankruptcy proceedings as it navigates a series of legal challenges.
Saudi Health Ministry reiterates that walking 8,000 steps daily strengthens the heart, increases activity, and reduces the risk of premature death.
Researchers at Baylor College of Medicine and Texas Children's Hospital's Duncan Neurological Research Institute (Duncan NRI) have identified a rare genetic change that appears to cause a newly…
